HEREDITARY AND FAMILIAL OVARIAN-CANCER IN SOUTHERN ONTARIO

被引:0
|
作者
NAROD, SA
MADLENSKY, L
BRADLEY, L
COLE, D
TONIN, P
ROSEN, B
RISCH, HA
机构
[1] MCGILL UNIV, DEPT MED, DIV MED GENET, MONTREAL, PQ, CANADA
[2] MCGILL UNIV, CTR HUMAN GENET, MONTREAL, PQ, CANADA
[3] TORONTO HOSP, DEPT OBSTET & GYNECOL, TORONTO M5T 2S8, ON, CANADA
[4] TORONTO HOSP, DEPT BIOCHEM, TORONTO M5T 2S8, ON, CANADA
[5] YALE UNIV, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, NEW HAVEN, CT 06520 USA
关键词
OVARIAN CANCER; BREAST CANCER; BRCA1; GENETIC COUNSELING;
D O I
10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Hereditary ovarian cancer may be site specific or may appear in combination with breast cancer or other cancers in a family. The most common hereditary form is the breast-ovarian cancer syndrome. It is estimated that in 100% of these families, there is linkage to a cancer susceptibility gene on chromosome 17q, BRCA1. Methods. A positive family history of breast or ovarian cancer was reported for 71 of 450 unselected cases of ovarian cancer identified in Southern Ontario. Detailed pedigrees were completed by telephone interview for 48 of the 71 subjects. Results. Nine families were identified with five or more cases of breast or ovarian cancer, 14 families with four cases of cancer, and eight families with three cases. Breast cancer appeared in 80% of the ovarian cancer families. There were 81 healthy first-degree female relatives of the cancer cases considered to be at high risk for ovarian cancer. Conclusions. It is feasible to use a simple questionnaire on all incident cases of ovarian cancer in a population to identify families with potential hereditary breast-ovarian cancer. Two point nine percent to 6.9% of cases of ovarian cancer appear to be inherited; the majority of the families also will have an excess number of cases of breast cancer.
引用
收藏
页码:2341 / 2346
页数:6
相关论文
共 50 条
  • [1] HEREDITARY OVARIAN-CANCER
    NERI, A
    RABINERSON, D
    KAPLAN, B
    LEVAVI, H
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1995, 31 (2-3): : 172 - 175
  • [2] ON FAMILIAL OVARIAN-CANCER
    CHUDINA, AP
    AKULENKO, LV
    PICHUGINA, MN
    POGOSYANZ, EE
    VOPROSY ONKOLOGII, 1980, 26 (12) : 84 - 90
  • [3] FAMILIAL OVARIAN-CANCER
    BULLER, RE
    ANDERSON, B
    CONNOR, JP
    ROBINSON, R
    GYNECOLOGIC ONCOLOGY, 1993, 51 (02) : 160 - 166
  • [4] FAMILIAL OVARIAN-CANCER
    VANEIJKEREN, MA
    DEGRAAFF, J
    VANETTEN, FHPM
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1992, 47 (03): : 263 - 266
  • [5] FAMILIAL OVARIAN-CANCER
    NGAN, HYS
    SHEPHERD, JH
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1994, 52 (2-3) : 99 - 102
  • [6] FAMILIAL OVARIAN-CANCER
    LURAIN, JR
    PIVER, MS
    GYNECOLOGIC ONCOLOGY, 1979, 8 (02) : 185 - 192
  • [7] FAMILIAL OVARIAN-CANCER
    SCHWARTZ, PE
    CANCER, 1995, 75 (10) : 2637 - 2637
  • [8] FAMILIAL OVARIAN-CANCER
    LURAIN, JR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (23): : 3343 - 3343
  • [9] FAMILIAL OVARIAN-CANCER REGISTRY
    PIVER, MS
    HOSPITAL PRACTICE, 1981, 16 (06): : 172 - 172
  • [10] FAMILIAL OVARIAN-CANCER REGISTRY
    PIVER, MS
    NORTH CAROLINA MEDICAL JOURNAL, 1981, 42 (06) : 420 - 420